loadpatents
Patent applications and USPTO patent grants for KASAHARA; Yuya.The latest application filed is for "molecular targeted nucleic acid medicine for gastric cancer".
Patent | Date |
---|---|
Molecular Targeted Nucleic Acid Medicine For Gastric Cancer App 20220282248 - KANDA; Mitsuro ;   et al. | 2022-09-08 |
Antisense Oligonucleic Acid App 20220170020 - OBIKA; Satoshi ;   et al. | 2022-06-02 |
Antisense oligonucleic acid Grant 11,261,440 - Obika , et al. March 1, 2 | 2022-03-01 |
.alpha.-synuclein expression inhibitor Grant 11,234,995 - Nakamori , et al. February 1, 2 | 2022-02-01 |
Antisense Oligonucleotide Targeting Arl4c Molecule, And Nucleic Acid Drug Using Antisense Oligonucleotide App 20210317459 - KIKUCHI; Akira ;   et al. | 2021-10-14 |
Small Cell Lung Cancer Therapeutic Agent Containing Oligonucleotide App 20210277398 - SHIMOJO; Masahito ;   et al. | 2021-09-09 |
Antisense Nucleic Acid For Inhibiting Biosynthesis Of Chondroitin App 20210102214 - OBIKA; Satoshi ;   et al. | 2021-04-08 |
Antisense Oligonucleic Acid App 20200056178 - OBIKA; Satoshi ;   et al. | 2020-02-20 |
a-SYNUCLEIN EXPRESSION INHIBITOR App 20190008886 - NAKAMORI; Masayuki ;   et al. | 2019-01-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.